These findings elucidate the transcriptional mechanism of macrophage‐driven angiogenesis in gynaecologic cancers and highlight the therapeutic potential of targeting NF‐κB signalling to reduce tumour vascularisation and immune suppression. This evidence concerns the gene NFKB1 and neoplasm.